• Accueil >
  • Publications >
  • Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy

Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy

1 mai 2019JAMA Oncology

DOI : 10.1001/jamaoncol.2018.6607

Auteurs

Stéphane Oudard, Igor Latorzeff, Armelle Caty, Laurent Miglianico, Emmanuel Sevin, Anne Claire Hardy-Bessard, Remy Delva, Frédéric Rolland, Loic Mouret, Franck Priou, Philippe Beuzeboc, Gwenaelle Gravis, Claude Linassier, Philippe Gomez, Eric Voog, Xavier Muracciole, Christine Abraham, Eugeniu Banu, Jean-Marc Ferrero, Alain Ravaud, Ivan Krakowski, Jean-Léon Lagrange, Gaël Deplanque, David Zylberait, Laurence Bozec, Nadine Houede, Stéphane Culine, Reza Elaidi